IBD Flashcards
Indications for azathioprine
- IBD
- DMARD for RA and other autoimmune conditions
- prevent organ rejection in transplant recipients
Azathioprine MOA
= pro drug
Main metabolite - 6 mercaptopurine. Its also metabolised and these inhibit synthesis of purines esp adenine and guanine. And so inhibit RNA replication.
Most cells recycle purines, lymphocytes depend on this .
Metabolisism and elimination are dependant on xanthine oxidase and TPMT. Some people naturally have less TPMT
SE azathioprine
BM supression = leukopenia and increased risk of infection. Reduce dose or take break to tackle.
Can do TPMT phenotype to identify the at risk
Nausea -reduce by dividing daily dose
Hypersensitivity reactions - D and V, rash, fever, myalgia, hypotension and pancreatitis
Veno occlusive disease
Hepatotoxic
Risk of lymphoma
Azathioprine CI
- absent TPMT activity
- hypersensitivity reactions
- teratogen but can continue if v necessary
reduce dose in
- less TPMT activity
- renal and hepatic impairment
interactions of azathioprine
- risk of infection if use with other supressants e.g. steroids.
- do not prescribe with xanthine oxidase-i
- risk of leukopenia if with other myelosupressive drugs = trimethoprim
- reduces effect of warfarin
how is azathioprine prescribed
1-3mg/kg dailuy in divided doses
monitoring azathioprine
- FBC weekly for first 4 weeks or after dose change and 3 monthly after.
can a fy1 start immunosupressants
no